Virus-Specific Effector CD4+ T-Cell Responses in Hemodialysis Patients with Hepatitis C Virus Infection

Journal of Medical Virology

Volumn 72, Issue 1, 2004, Pages 66-74

  Rico, Miguel A ^a   Ruiz, Sara ^a   Subirá, Dolores ^b   Barril, Guillermina ^c   Cigarrán, Secundino ^c   Castañón, Susana ^b   Quiroga, Juan A ^a   Selgas, Rafael ^c   Carreño, Vicente ^a  

^a Fundacion Estudio Hepatitis Virales   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Anti HCV antibodies; Chronic renal failure; Hemodialysis; Hepatitis C virus (HCV) infection; Virus specific effector CD4+ T helper (Th) cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; HEPATITIS C ANTIBODY; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEMODIALYSIS; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MALE; PHENOTYPE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIREMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY FAILURE, CHRONIC; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RENAL DIALYSIS; T-LYMPHOCYTES, REGULATORY;

CYTOMEGALOVIRUS; HEPATITIS C VIRUS;

EID: 0344443729     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10551     Document Type: Article

References (47)

1. Alter MJ. 1999. Hepatitis C virus infection in Western Europe. J Hepatol 31(Suppl 1):88-91.
2. Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, Cooper DA, Rowland-Jones SL, Kelleher AD. 2002. Characterization of CD4(+) CTLs ex vivo. J Immunol 168:5954-5958.
3. Baars PA, Maurice MM, Rep M, Hooibrink B, Lier RA. 1995. Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27-T cell subset contains specialized primed T-cells. J Immunol 154:17-25.
4. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512-524.
5. Barnes E, Harcourt G, Brown D, Lucas M, Phillips R, Dusheiko G, Klenerman P. 2002. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36:743-754.
6. Barril G. 2000. Hepatitis C virus-induced liver disease in dialysis patients. Nephrol Dial Transplant 15(Suppl 8):42-45.
7. Bertoletti A, Maini MK. 2000. Protection or damage: A dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Immunol 12:403-408.
8. Brosterhus H, Brings S, Leyendeckers H, Manz RA, Miltenyi S, Radbruch A, Assenmacher M, Schmitz J. 1999. Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion. Eur J Immunol 29:4053-4059.
9. Caramelo C, Bartolome J, Albalate M, de Sequera P, Navas S, Bermejillo T, Oliva H, Marriott E, Ortiz A, Ruiz Tunon C, Casado S, Carreno V. 1996. Undiagnosed hepatitis C virus infection in hemodialysis patients: Value of HCV RNA and liver enzyme levels. Kidney Int 50:2027-2031.
10. Centres for Disease Control and Prevention. 2001. Recommendations for preventing transmission of infections among chronic hemodialysis patients. Morb Mort Wkly Rep 50(RR-5):1-43.
11. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118:346-355.
12. De Oliveira JM, Rispeter K, Viazov S, Saback FL, Roggendorf M, Yoshida CF. 2001. Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate. J Med Virol 63:265-270.
13. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Sanantonio T, Jung MC, Eichenlaub D, Pape GR. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006-1007.
14. Eckels DD, Tabatabail N, Bian TH, Wang H, Muheisen SS, Rice CM, Yoshizawa K, Gill J. 1999. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: Failure in IL-2 production despite proliferation. Hum Immunol 60:187-199.
15. Einav S, Koziel MJ. 2002. Immunopathogenesis of hepatitis C virus in the immunosuppressed host. Transpl Infect Dis 4:85-92.
16. Fabrizi F, Poordad FF, Martin P. 2002. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36:3-10.
17. Godkin A, Jeanguet N, Thursz M, Openshaw P, Thomas H. 2001. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol 31:1438-1446.
18. Godkin AJ, Thomas HC, Openshaw PJ. 2002. Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus. J Immunol 169:2210-2214.
19. Goicoechea M, Martin J, de Sequera P, Quiroga JA, Ortiz A, Carreno V, Caramelo C. 1998. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 54:1337-1343.
20. Hanuka N, Sikuler E, Tovbin D, Mostoslavsky M, Hausman M, Orgel M, Yaari A, Shemer-Avni Y. 2002. Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Viral Hepat 9:141-145.
21. Hempel G, Galle PR, Löhr HF. 2001. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C. J Med Virol 64:340-349.
22. Hengel RL, Thaker V, Pavlick MV, Metcalf JA, Dennis G, Jr., Yang J, Lempicki RA, Sereti I, Lane HC. 2003. L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen. J Immunol 170:28-32.
23. Hintzen RQ, de Jong R, Lens SM, Brouwer M, Baars P, van Lier RA. 1993. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 15:2426-2435.
24. Kamal SM, Fehr J, Roesler B, Peters T, Rasenak JW. 2002. Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123:1070-1083.
25. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, Sasaki Y, Kasahara A, Hori M. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162:5584-5591.
26. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. 2003. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388-392.
27. Laouar Y, Crispe IN. 2000. Functional flexibility in T cells: Independent regulation of CD4+ T cell proliferation and effector function in vivo. Immunity 13:291-301.
28. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
29. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499-1512.
30. Li H, Llera A, Malchiodi EL, Mariuzza RA. 1999. The structural basis of T cell activation by superantigens. Annu Rev Immunol 17:435-466.
31. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. 2000. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 132:296-305.
32. Löhr HF, Schlaak JF, Kollmannsperger S, Dienes HP, Meyer zum Buschenfelde KH, Gerken G. 1996. Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: Immunodominant epitopes, HLA-restriction and functional significance. Liver 16:174-182.
33. MacDonald AJ, Duffy M, Brady MT, McKiernan S, Hall W, Hegarty J, Curry M, Mills KH. 2002. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 185:720-727.
34. Martin J, de Sequera P, Quiroga JA, Rico M, Fernandez M, Arocena C, Caramelo C, Carreno V. 2000. Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Cytokine 12:1248-1252.
35. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 98:706-714.
36. Penna A, Missale G, Lamonaca V, Pilli M, Mori C, Zanelli P, Cavalli A, Elia G, Ferrari C. 2002. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: Functional characterization in patients with chronic hepatitis C. Hepatology 35:225-1236.
37. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. 2000. Clinical relevance of cytokine production in hemodialysis. Kidney Int 58(Suppl 76):S104-S111.
38. Pol S, Vallet-Pichard A, Fontaine H, Lebray P. 2002. HCV infection and hemodialysis. Semin Nephrol 22:331-339.
39. Rehermann B. 2000. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 20:127-141.
40. - T-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels. J Hepatol 36:408-416.
41. Romagnani S. 2000. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85:9-18.
42. Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ. 2002. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages. Hepatology 35:190-198.
43. Rostaing L, Borde JS, Hasle C, Bories P, Allal A, Abbal M, Durand D. 2001. Lack of effect of chronic hepatitis C virus infection on T-cell cytokine production in chronic hemodialysis patients. Am J Nephrol 21:194-199.
44. Schneeberger PM, Keur I, van der Vliet W, van Hoek K, Boswijk H, van Loon AM, van Dijk WC, Kauffmann RH, Quint W, van Doorn LJ. 1998. Hepatitis C virus infections in dialysis centers in The Netherlands: A national survey by serological and molecular methods. J Clin Microbiol 36:1711-1715.
45. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-1406.
46. Trepo C, Pradat P. 1999. Hepatitis C virus infection in Western Europe. J Hepatol 31(Suppl 1):80-83.
47. Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM. 2003. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37:1189-1198.